These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22008773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment.
    Kurbatova EV, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1553-5, i. PubMed ID: 22008772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018 Nov; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 5. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.
    Ann Intern Med; 2006 May 02; 144(9):650-9. PubMed ID: 16670134
    [Abstract] [Full Text] [Related]

  • 6. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
    Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ.
    Int J Tuberc Lung Dis; 2011 Oct 02; 15(10):1315-22. PubMed ID: 22283887
    [Abstract] [Full Text] [Related]

  • 7. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Oct 02; 16(10):1335-43. PubMed ID: 23107633
    [Abstract] [Full Text] [Related]

  • 8. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
    Qi W, Harries AD, Hinderaker SG.
    Int J Tuberc Lung Dis; 2011 Jan 02; 15(1):137-9. PubMed ID: 21276311
    [Abstract] [Full Text] [Related]

  • 9. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Abebe M, Atnafu A, Tilahun M, Sero N, Neway S, Alemu M, Tesfaye G, Mihret A, Bobosha K, Wan C.
    PLoS One; 2024 Jan 02; 19(5):e0304507. PubMed ID: 38820260
    [Abstract] [Full Text] [Related]

  • 10. Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan.
    Irfan S, Rao N, Irfan M, Iftikhar I, Azizullah Z, Jabeen K, Hasan R.
    Int J Tuberc Lung Dis; 2019 Jul 01; 23(7):838-843. PubMed ID: 31439116
    [Abstract] [Full Text] [Related]

  • 11. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Reimann M, Schaub D, Kalsdorf B, Runge C, Carballo PS, Terhalle E, Salzer HJF, Lange C, Heyckendorf J.
    Int J Tuberc Lung Dis; 2019 Jan 01; 23(1):93-98. PubMed ID: 30674380
    [Abstract] [Full Text] [Related]

  • 12. Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China.
    Chen Q, He W, Du J, Kang W, Zou L, Tang X, Tang P, Guo C, Pan Q, Zhu Q, Yang S, Guo Z, Wu G, Tang S.
    Antimicrob Resist Infect Control; 2024 Oct 15; 13(1):126. PubMed ID: 39407338
    [Abstract] [Full Text] [Related]

  • 13. Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study.
    Basit A, Ahmad N, Khan AH, Javaid A, Syed Sulaiman SA, Afridi AK, Adnan AS, Haq Iu, Shah SS, Ahadi A, Ahmad I.
    PLoS One; 2014 Oct 15; 9(4):e93206. PubMed ID: 24705411
    [Abstract] [Full Text] [Related]

  • 14. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK, Holtz TH, Riekstina V, Leimane V.
    Int J Tuberc Lung Dis; 2011 Nov 15; 15(11):1546-52, i. PubMed ID: 22008771
    [Abstract] [Full Text] [Related]

  • 15. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China.
    Liu Q, Lu P, Martinez L, Yang H, Lu W, Ding X, Zhu L.
    BMC Infect Dis; 2018 Mar 06; 18(1):114. PubMed ID: 29510666
    [Abstract] [Full Text] [Related]

  • 16. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.
    Int J Tuberc Lung Dis; 2013 Mar 06; 17(3):348-53. PubMed ID: 23321297
    [Abstract] [Full Text] [Related]

  • 17. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.
    Int J Tuberc Lung Dis; 2012 Jun 06; 16(6):805-11. PubMed ID: 22390880
    [Abstract] [Full Text] [Related]

  • 18. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.
    Int J Tuberc Lung Dis; 2012 Sep 06; 16(9):1228-33. PubMed ID: 22748131
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    Alene KA, Viney K, Yi H, McBryde ES, Yang K, Bai L, Gray DJ, Xu Z, Clements ACA.
    PLoS One; 2018 Sep 06; 13(5):e0197880. PubMed ID: 29791488
    [Abstract] [Full Text] [Related]

  • 20. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS, Kumar AM, Claassens M, Banurekha VV, Sekar G, Venkatesan P, Swaminathan S.
    Int J Tuberc Lung Dis; 2014 Apr 06; 18(4):449-53. PubMed ID: 24670701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.